Association of biomarkers of endothelial function, inflammation, and neurodegenerative diseases with arteriosclerotic cerebral small vessel disease

doi:10.11817/j.issn.1673-9248.2023.01.011

Abstract

Abstract:

Cerebral small vessel disease (CSVD) is a major cause of dementia in elderly. Some studies showed that biomarkers of endothelial dysfunction, inflammation and neurodegenerative diseases are associated with arteriosclerotic CSVD, which may indicated the development of CSVD. The review summaries these biomarkers to provide an insight into the pathogenesis, early diagnosis and treatment in CSVD.

Key words: Cerebral small vessel disease, Endothelial dysfunction, Inflammation, Neurodegenerative diseases, Biomarker

Zhuoran Li, Wenli Hu. Association of biomarkers of endothelial function, inflammation, and neurodegenerative diseases with arteriosclerotic cerebral small vessel disease[J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2023, 17(01): 57-60.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhnxgbzz.cma-cmc.com.cn/EN/10.11817/j.issn.1673-9248.2023.01.011

https://zhnxgbzz.cma-cmc.com.cn/EN/Y2023/V17/I01/57

References 44

1	Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications [J]. Lancet Neurol, 2019, 18(7): 684-696.
2	胡文立, 杨磊, 李譞婷, 等. 中国脑小血管病诊治专家共识2021 [J]. 中国卒中杂志, 2021, 16(7): 716-726.
3	Auriel E, Csiba L, Berenyi E, et al. Leukoaraiosis is associated with arterial wall thickness: a quantitative analysis [J]. Neuropathology, 2012, 32(3): 227-233.
4	Munoz DG. Leukoaraiosis and ischemia: beyond the myth [J]. Stroke, 2006, 37(6): 1348-1349.
5	Zhang CE, Wong SM, van de Haar HJ, et al. Blood-brain barrier leakage is more widespread in patients with cerebral small vessel disease [J]. Neurology, 2017, 88(5): 426-432.
6	Nezu T, Hosomi N, Aoki S, et al. Endothelial dysfunction is associated with the severity of cerebral small vessel disease [J]. Hypertens Res, 2015, 38(4): 291-297.
7	De Guio F, Vignaud A, Ropele S, et al. Loss of venous integrity in cerebral small vessel disease: a 7-T MRI study in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) [J]. Stroke, 2014, 45(7): 2124-2126.
8	Charidimou A, Pantoni L, Love S. The concept of sporadic cerebral small vessel disease: A road map on key definitions and current concepts [J]. Int J Stroke, 2016, 11(1): 6-18.
9	O'Sullivan M, Lythgoe DJ, Pereira AC, et al. Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis [J]. Neurology, 2002, 59(3): 321-326.
10	Hainsworth AH, Fisher MJ. A dysfunctional blood-brain barrier and cerebral small vessel disease [J]. Neurology, 2017, 88(5): 420-421.
11	Li Y, Li M, Zhang X, et al. Higher blood-brain barrier permeability is associated with higher white matter hyperintensities burden [J]. J Neurol, 2017, 264(7): 1474-1481.
12	Wiseman S, Marlborough F, Doubal F, et al. Blood markers of coagulation, fibrinolysis, endothelial dysfunction and inflammation in lacunar stroke versus non-lacunar stroke and non-stroke: systematic review and meta-analysis [J]. Cerebrovasc Dis, 2014, 37(1): 64-75.
13	Kloppenborg RP, Geerlings MI, Visseren FL, et al. Homocysteine and progression of generalized small-vessel disease: the SMART-MR Study [J]. Neurology, 2014, 82(9): 777-783.
14	Simpson JE, Fernando MS, Clark L, et al. White matter lesions in an unselected cohort of the elderly: astrocytic, microglial and oligodendrocyte precursor cell responses [J]. Neuropathol Appl Neurobiol, 2007, 33(4): 410-419.
15	Pantoni L, Inzitari D, Pracucci G, et al. Cerebrospinal fluid proteins in patients with leucoaraiosis: possible abnormalities in blood-brain barrier function [J]. J Neurol Sci, 1993, 115(2): 125-131.
16	Wada M, Nagasawa H, Kurita K, et al. Microalbuminuria is a risk factor for cerebral small vessel disease in community-based elderly subjects [J]. J Neurol Sci, 2007, 255(1-2): 27-34.
17	Vermeer SE, van Dijk EJ, Koudstaal PJ, et al. Homocysteine, silent brain infarcts, and white matter lesions: the Rotterdam Scan Study [J]. Ann Neurol, 2002, 51(3): 285-289.
18	Piao X, Wu G, Yang P, et al. Association between Homocysteine and cerebral small vessel disease: a meta-analysis [J]. J Stroke Cerebrovasc Dis, 2018, 27(9): 2423-2430.
19	Markus HS, Hunt B, Palmer K, et al. Markers of endothelial and hemostatic activation and progression of cerebral white matter hyperintensities [J]. Stroke, 2005, 36(7): 1410-1414.
20	Wu BN, Wu J, Hao DL, et al. High serum sICAM-1 is correlated with cerebral microbleeds and hemorrhagic transformation in ischemic stroke patients [J]. Br J Neurosurg, 2018, 32(6): 631-636.
21	Yang Y, Estrada EY, Thompson JF, et al. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat [J]. J Cereb Blood Flow Metab, 2007, 27(4): 697-709.
22	Piao MS, Lee JK, Park CS, et al. Early activation of matrix metalloproteinase-9 is associated with blood-brain barrier disruption after photothrombotic cerebral ischemia in rats [J]. Acta Neurochir (Wien), 2009, 151(12): 1649-1653.
23	Nakaji K, Ihara M, Takahashi C, et al. Matrix metalloproteinase-2 plays a critical role in the pathogenesis of white matter lesions after chronic cerebral hypoperfusion in rodents [J]. Stroke, 2006, 37(11): 2816-2823.
24	Liu J, Jin X, Liu KJ, et al. Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage [J]. J Neurosci, 2012, 32(9): 3044-3057.
25	Wright CB, Moon Y, Paik MC, et al. Inflammatory biomarkers of vascular risk as correlates of leukoariosis [J]. Stroke, 2009, 40(11): 3466-3471.
26	Miwa K, Tanaka M, Okazaki S, et al. Relations of blood inflammatory marker levels with cerebral microbleeds [J]. Stroke, 2011, 42(11): 3202-3206.
27	Lindbergh CA, Casaletto KB, Staffaroni AM, et al. Systemic tumor necrosis factor-alpha trajectories relate to brain health in typically aging older adults [J]. J Gerontol A Biol Sci Med Sci, 2020, 75(8): 1558-1565.
28	Jefferson AL, Massaro JM, Wolf PA, et al. Inflammatory biomarkers are associated with total brain volume: the Framingham Heart Study [J]. Neurology, 2007, 68(13): 1032-1038.
29	Nicholls SJ, Hazen SL. Myeloperoxidase and cardiovascular disease [J]. Arterioscler Thromb Vasc Biol, 2005, 25(6): 1102-1111.
30	Shoamanesh A, Preis SR, Beiser AS, et al. Inflammatory biomarkers, cerebral microbleeds, and small vessel disease: Framingham Heart Study [J]. Neurology, 2015, 84(8): 825-832.
31	Provenzano FA, Muraskin J, Tosto G, et al. White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease? [J]. JAMA Neurol, 2013, 70(4): 455-461.
32	Erten-Lyons D, Woltjer R, Kaye J, et al. Neuropathologic basis of white matter hyperintensity accumulation with advanced age [J]. Neurology, 2013, 81(11): 977-983.
33	Niwa K, Younkin L, Ebeling C, et al. Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation [J]. Proc Natl Acad Sci U S A, 2000, 97(17): 9735-9740.
34	Habes M, Pomponio R, Shou H, et al. The Brain Chart of Aging: Machine-learning analytics reveals links between brain aging, white matter disease, amyloid burden, and cognition in the iSTAGING consortium of 10,216 harmonized MR scans [J]. Alzheimers Dement, 2021, 17(1): 89-102.
35	Gomis M, Sobrino T, Ois A, et al. Plasma beta-amyloid 1-40 is associated with the diffuse small vessel disease subtype [J]. Stroke, 2009, 40(10): 3197-3201.
36	van Leijsen EMC, Kuiperij HB, Kersten I, et al. Plasma Aβ (Amyloid-β) levels and severity and progression of small vessel disease [J]. Stroke, 2018, 49(4): 884-890.
37	Romero JR, Demissie S, Beiser A, et al. Relation of plasma β-amyloid, clusterin, and tau with cerebral microbleeds: Framingham Heart Study [J]. Ann Clin Transl Neurol, 2020, 7(7): 1083-1091.
38	McAleese KE, Firbank M, Dey M, et al. Cortical tau load is associated with white matter hyperintensities [J]. Acta Neuropathol Commun, 2015, 3: 60.
39	Tosto G, Zimmerman ME, Hamilton JL, et al. The effect of white matter hyperintensities on neurodegeneration in mild cognitive impairment [J]. Alzheimers Dement, 2015, 11(12): 1510-1519.
40	Deters KD, Risacher SL, Kim S, et al. Plasma tau association with brain atrophy in mild cognitive impairment and Alzheimer's disease [J]. J Alzheimers Dis, 2017, 58(4): 1245-1254.
41	Mollenhauer B, Dakna M, Kruse N, et al. Validation of serum neurofilament light chain as a biomarker of Parkinson's disease progression [J]. Mov Disord, 2020, 35(11): 1999-2008.
42	Duering M, Konieczny MJ, Tiedt S, et al. Serum neurofilament light chain levels are related to small vessel disease burden [J]. J Stroke, 2018, 20(2): 228-238.
43	Egle M, Loubiere L, Maceski A, et al. Neurofilament light chain predicts future dementia risk in cerebral small vessel disease [J]. J Neurol Neurosurg Psychiatry, 2021, 92(6): 582-589.
44	Qu Y, Tan CC, Shen XN, et al. Association of plasma neurofilament light with small vessel disease burden in nondemented elderly: A Longitudinal Study [J]. Stroke, 2021, 52(3): 896-904.

[1]	Chun Yi, Dongsheng Yuan, Xuejun Xiong. Relationship of systemic immune-inflammation index with decreased bone mass density and osteoporosis [J]. Chinese Journal of Joint Surgery(Electronic Edition), 2024, 18(05): 609-617.
[2]	Dan Tang, Xiaoxi Yao, Bowen Yang, Shaolong Xue, Mengyao Li, Liuxing Wei, Mingrong Xi. The impact of doublecortin-like kinase 1 on the clinical characteristics of endometrioid adenocarcinoma patients [J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 582-590.
[3]	Xiaowei Chang, Yu Cai, Zhiyong Zhao, Wei Zhang. Efficacy and safety analysis of high intensity focused ultrasound ablation combined with hepatic arterial chemoembolization in the treatment of primary hepatocellular carcinoma [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(01): 56-59.
[4]	Jie Zhang, Xiaoxia Luo, Hong Yu. Predictive value of systemic immune inflammation index in patients with acute pancreatitis complicated with organ function impairment [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(01): 68-71.
[5]	Mei Tang, Li Zhou, Cenyue Niu, Xiaotong Zhou, Qian Wang. Clinical significance of ICG fluorescence guided laparoscopic hepatectomy [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(06): 655-658.
[6]	Zhongwen Liu, Chang Liu, Yang Gao, Dong Liu, Shiqing Lin, Jianhua Yang, Fuyi Zhao. Correlation of urinary microRNA-326 with the prognosis of bladder cancer patients treated with radical cystectomy [J]. Chinese Journal of Endourology(Electronic Edition), 2024, 18(04): 386-391.
[7]	Lu Sun, Yaling Jiang, Lingjun Chen. Effect of butorphanol on neuroinflammation and JAK2/STAT3 signaling pathway in rats with cerebral ischemia-reperfusion injury [J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2024, 14(06): 344-350.
[8]	Yuhan Yuan, Shengli Yang. Research progress in proteomic analysis of body fluids and tissues in early molecular diagnosis of liver cancer [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 883-888.
[9]	Rongrong Feng, Xiaole Su, Lihua Wang. Research progress on biological markers related to complication of cardiovascular disease in patients with chronic kidney disease [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(05): 273-278.
[10]	Xia Du, Mengqing Ma, Changchun Cao. Research progress on the pathogenesis and intervention targets of contrast-induced acute kidney injury [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(05): 279-282.
[11]	Li Hang, Yaohui Zhang, Wenkai Sun. Effect of Shenba Kangliu Liquid on intestinal function, inflammatory index and recurrence after colorectal adenomatous polyp surgery [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2024, 14(05): 413-416.
[12]	Xin Tan, Pengyuan Wang, Lianghao Hu. Research progress on anti-inflammatory and anti-fibrotic therapy for chronic pancreatitis [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2024, 14(04): 289-296.
[13]	Ziyang Wang, Hongbin Wang, Xiaojing Liu. Progress in research of serum markers for diagnosis of alpha-fetoprotein negative hepatocellular carcinoma [J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(07): 677-681.
[14]	Weiwei Zhao, Yuhua Zhao, Xiaoxuan Liu. Correlation between MTHFR C677T polymorphism and cerebral microbleeds in Tibet area [J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2024, 18(05): 473-478.
[15]	Wanrui Shi, Ligang Cui. Advances in imaging diagnosis of transient perivascular inflammation of the carotid artery [J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2024, 18(05): 516-519.

Please choose a citation manager

Content to export